Healthcare Services

Preimplantation Genetic Testing Industry Expansion Forecast Showing Market Size of $1.56 Billion by 2030 at 11.1% CAGR

April 6, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Preimplantation Genetic Testing Market In 2026 And What Value Is Projected For 2030?

The preimplantation genetic testing market has experienced significant expansion in recent years. Its value is projected to climb from $0.92 billion in 2025 to $1.03 billion in 2026, indicating a compound annual growth rate (CAGR) of 11.4%. This historical growth can be ascribed to the increasing adoption of assisted reproductive technologies, enhancements in embryo biopsy techniques, a rising awareness of genetic disease prevention, the proliferation of fertility clinics, and improved success rates in IVF procedures.

The preimplantation genetic testing market size is anticipated to experience significant expansion over the coming years. This market is projected to reach $1.57 billion by 2030, driven by a compound annual growth rate (CAGR) of 11.1%. Factors contributing to this growth during the forecast period include the increasing demand for personalized reproductive medicine, the growing adoption of advanced genomic technologies, the expansion of fertility preservation services, rising investment in reproductive health infrastructure, and the increasing regulatory acceptance of genetic screening. Key trends during the forecast period encompass the increasing adoption of embryo screening procedures, the rising utilization of next-generation sequencing in IVF, the broadening of genetic testing within fertility treatments, a growing demand for enhanced implantation success rates, and a heightened focus on mitigating genetic disorders.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20596&type=smp

What Key Drivers Are Influencing The Growth Of The Preimplantation Genetic Testing Market?

The rising volume of in vitro fertilization (IVF) procedures is projected to spur the expansion of the preimplantation genetic testing market moving forward. IVF procedures involve fertilizing an egg with sperm outside the body to form an embryo, which is then implanted into the uterus. The growth in IVF procedures is fueled by advancements in reproductive technology, escalating infertility rates, and heightened public awareness. This surge in in vitro fertilization (IVF) procedures is boosting the preimplantation genetic testing market by increasing the need for genetic screening of embryos before their implantation. For instance, in June 2025, the Human Fertilisation & Embryology Authority, a UK-based independent regulator of fertility treatment, reported that in 2023, 52,400 patients underwent over 77,500 in vitro fertilization (IVF) cycles at licensed fertility clinics across the UK. Furthermore, egg freezing cycles climbed from 4,700 in 2022 to 6,900 in 2023, constituting 7% of all cycles. Consequently, the increasing number of in vitro fertilization (IVF) procedures is a key driver for the preimplantation genetic testing market.

What Are The Key Segments Of The Preimplantation Genetic Testing Market?

The preimplantation genetic testing market covered in this report is segmented –

1) By Procedure: Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis

2) By Product: Reagents And Consumables, Instruments, Software

3) By Technology: Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In Situ Hybridization (FISH), Other Technologies

4) By Application: Chromosomal Abnormalities, Aneuploidy Screening, X-Linked Diseases, Embryo Testing, Human Leukocyte Antigen (HLA) Typing, Other Applications

5) By End User: Hospitals, Fertility Centers, Diagnostic Centers, Research Centers And Academic Labs

Subsegments:

1) By Preimplantation Genetic Screening (PGS): Array Comparative Genomic Hybridization (aCGH), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH)

2) By Preimplantation Genetic Diagnosis (PGD): Monogenic Disorders Testing, Chromosomal Abnormalities Testing, HLA Typing for Stem Cell Transplantation

How Are Trends Impacting The Preimplantation Genetic Testing Market?

Leading companies in the preimplantation genetic testing market are actively developing sophisticated next-generation sequencing (NGS) tools to elevate the precision, efficiency, and speed of genetic screening. This enables more extensive analysis and supports prospective parents in making better-informed decisions. Next-generation sequencing (NGS) tools accelerate genetic research by providing rapid, high-throughput analysis of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). They deliver detailed insights into genetic variations and gene expression, thereby boosting accuracy and facilitating personalized medicine. For example, in July 2023, Thermo Fisher Scientific, a US-based biotechnology company, launched the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit. These are advanced next-generation sequencing tools specifically designed to enhance IVF and ICSI research. These assays streamline workflows, from sample processing to aneuploidy analysis, utilizing cutting-edge technology on the Ion Torrent Genexus integrated sequencer. This represents a significant advancement within the preimplantation genetic testing market by improving embryo screening and increasing success rates in assisted reproductive technologies.

Who Are The Leading Companies Operating In The Preimplantation Genetic Testing Market?

Major companies operating in the preimplantation genetic testing market are Thermo Fisher Scientific, Abbott Laboratories, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Illumina Inc., Revvity Health Science Inc., CooperSurgical Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, Takara Bio Inc., MedGenome Labs Ltd., Genea Limited, Ovation Fertility, Juno Genetics Ltd, Invicta Genetics, Progenesis, Bioarray SL, PacGenomics, Reproductive Genetic Innovations LLC, SEQUENCE46 LLC

Read the full preimplantation genetic testing market report here:

https://www.thebusinessresearchcompany.com/report/preimplantation-genetic-testing-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Preimplantation Genetic Testing Market?

North America was the largest region in the preimplantation genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the preimplantation genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Preimplantation Genetic Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20596&type=smp

Browse Through More Reports Similar to the Global Preimplantation Genetic Testing Market 2026, By The Business Research Company

Pediatric And Neonatal Testing Kit Global Market Report

https://www.thebusinessresearchcompany.com/report/pediatric-and-neonatal-testing-kit-global-market-report

Ovulation Testing Kits Global Market Report

https://www.thebusinessresearchcompany.com/report/ovulation-testing-kits-global-market-report

Dna Test Kits Global Market Report

https://www.thebusinessresearchcompany.com/report/dna-test-kits-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795